Additionally, Matsuda et al. confirmed that miR-26 was a tumor suppressor that was linked to advanced CTCL invasion and metastasis via modulating the IL-22-STAT3-CCL20 cascade. The gene discussed is CCL20; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.